LANGHORNE, PA — NEXGEL Inc. (NASDAQ: NXGL) announced it has signed a definitive agreement to license and acquire a portfolio ...

Announcing a new article publication for BIO Integration journal. Osteochondral damage is primarily caused by degeneration of articular cartilage due to trauma, degenerative injury. Current approaches ...

Method A. Sodium ALE (0.25 mmol) was dissolved in 10% aqueous acetic acid and the solution was frozen and lyophilized. The free carboxylic group of Resomer RG 502 H was activated by dissolving the ...

NexGel Inc. NXGL on Tuesday agreed to license and acquire a portfolio of commercial-stage regenerative biomaterial products from Celularity, Inc. CELU, a regenerative and cellular medicine company.

Tissue Engineering (TE) strategies combining stem cells, biomaterial scaffolds, and biochemical/physical cues have emerged as promising approaches for the repair/replacement of injured tissues and ...